Norstella and Citeline (formerly Pharma Intelligence) have merged to form a $5 billion global company, one of the largest pharma intelligence solutions providers on the market.
Norstella now has more than 1,500 employees across its five brands: Evaluate, MMIT, Panalgo, The Dedham Group, and Citeline.
“We believe that patient access starts with identifying unmet needs and doesn’t end until a patient has a therapy in hand,” commented Mike Gallup, CEO of Norstella.
We’re looking for agile, growth-oriented team players who are passionate about client success and helping clients bring life-saving therapies to market quicker—and help patients in need.
Work with us
Have questions about Norstella or its brands? Or do you want to know more about how to solve your challenges at each stage of the drug life cycle?
We want to hear from you